Default company panoramic image
32ec6275 39c0 42a6 9851 5c5b92d724e7

Remedor Biomed

Remedor Biomed is a biopharmaceutical company developing novel Erythropoietin/Fibronectin combinations for wound healing treatment.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Israel
  • Currency ILS
  • Founded December 2009
  • Employees 6
  • Website remedor.com

Company Summary

The Remedor Biomed technology platform is based on the combination of two naturally-occurring glycoproteints: erythropoietin (EPO) and fibronectin (FN).
The combined topical administration of these two proteins has been shown to have a synergistic effect that promotes wound healing and connective tissue reconstruction.
Due to the successful preclinical studies, the company is currently preparing for Phase I clinical studies.